Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy?
Cathie Wood isn't known for being a value investor. However, the Ark Invest CEO won't pass up the opportunity to scoop up shares of innovative companies when they're available at a lower price.
That's exactly what Wood and her investment firm have been doing with one stock, in particular, in recent months. Last week, Ark Invest added $5 million worth of Pacific Biosciences of California (NASDAQ: PACB) (PacBio) as its steep pullback continued.
Given Wood's interest and the fact that the stock is trading at a discount, is PacBio stock a no-brainer buy right now?
Source Fool.com
Pacific Biosciences of California Inc. Aktie
1,46 €
7,37 %
Die Community unterstützt Pacific Biosciences of California Inc. leicht, mit mehr Buy- als Sell-Einschätzungen.
Mit einem Kursziel von 9 € für Pacific Biosciences of California Inc., würde dies eine mehr als zweifache Steigerung des aktuellen Kurses von 1.46 € bedeuten.
